Best Drug Manufacturers - Specialty & Generic Stocks in the United States for 2026

Top-ranked Drug Manufacturers - Specialty & Generic stocks in United States. Specialty and generic drugmakers compound on volume and niche pricing rather than branded margins, so Valuation leads with Health covering debt service and FDA exposure.

Specialty and Generic Drug Manufacturers earn lower gross margins than big pharma but compound on volume and niche pricing. Composite ranking uses the Valuation pillar as the primary signal (the cohort is structurally cheaper than branded pharma) with Health pillar (debt service, FDA exposure) as the safety floor.

Data as of (updated daily)

Top 20 Drug Manufacturers - Specialty & Generic stocks in United States by composite score

#TickerNameComposite
1NBIX.USNeurocrine Biosciences Inc75.7
2ANIP.USANI Pharmaceuticals Inc70.7
3UTHR.USUnited Therapeutics Corporation62.2
4KNSA.USKiniksa Pharmaceuticals Ltd62.0
5LQDA.USLiquidia Technologies Inc61.5
6BCRX.USBioCryst Pharmaceuticals Inc61.5
7INDV.USIndivior PLC Ordinary Shares61.3
8AMRX.USAmneal Pharmaceuticals, Inc. Class A Common Stock60.5
9INM.USInMed Pharmaceuticals Inc60.3
10PAHC.USPhibro Animal Health Corporation59.4
11LNTH.USLantheus Holdings Inc58.8
12SNOA.USSonoma Pharmaceuticals Inc58.5
13XERS.USXeris Pharmaceuticals Inc58.3
14ETON.USEton Pharmaceuticals Inc58.3
15SUPN.USSupernus Pharmaceuticals, Inc.57.6
16GELS.USGelteq Limited Ordinary Shares56.8
17PRFX.USPRF Technologies Ltd.55.6
18SIGA.USSIGA Technologies Inc55.6
19BGM.USBGM Group Ltd.55.4
20OPTH.USOptimi Health Corp. Common Shares55.2

Customise the Drug Manufacturers - Specialty & Generic + United States screen

The full screener applies both filters and lets you stack 30+ more on top: market cap, dividend yield, and the four pillar scores.

Open in screener →

Methodology: How we score stocks. Data refreshed nightly around 03:30 ET. This page lists the top 20 by composite score within the Drug Manufacturers - Specialty & Generic industry, the United States. Use the screener for the full ranked list.

By using ShareValue.ai you agree to our Terms and Privacy Policy. Educational platform, not investment advice.